| 000 | 01644 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517062656.0 | ||
| 264 | 0 | _c20160219 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1460-2105 | ||
| 024 | 7 |
_a10.1093/jnci/djv335 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeidner, Joshua F | |
| 245 | 0 | 0 |
_aPhase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cMar 2016 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNational Cancer Institute (U.S.) |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aKarp, Judith E | |
| 700 | 1 | _aBlackford, Amanda L | |
| 700 | 1 | _aFoster, Matthew C | |
| 700 | 1 | _aDees, E Claire | |
| 700 | 1 | _aSmith, Gary | |
| 700 | 1 | _aIvy, S Percy | |
| 700 | 1 | _aHarris, Pamela | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 108 _gno. 3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/djv335 _zAvailable from publisher's website |
| 999 |
_c25435191 _d25435191 |
||